Latest News

Despite an already strong run, Bayer Aktiengesellschaft ( ETR:BAYN ) shares have been powering on, with a gain of 29...

Peak Processing Limited's ( ASX:PKP ) price-to-sales (or "P/S") ratio of 1.2x might make it look like a strong buy...

Long term investing works well, but it doesn't always work for each individual stock. We really hate to see fellow...

Dynex Capital (DX) has wrapped up FY 2025 with Q4 total revenue of US$202.0 million and basic EPS of US$1.17, alongside trailing twelve month revenue of US$372.1 million and EPS of US$2.49. This sits next to a very large 190.8% earnings jump over the past year and an 11.4% annual earnings decline over five years. The company has seen quarterly revenue move from US$60.3 million in Q4 2024 to US$201.997 million in Q4 2025, while basic EPS shifted from US$0.61 to US$1.17 over the same period...

After a strong run, you might be wondering whether Karooooo is still reasonably priced or starting to look stretched at current levels. The stock last closed at US$50.84, with returns of 8.6% over the past week, 7.3% over the last month, 13.8% year to date, and 19.6% over the past year. This puts recent price action front and center for anyone thinking about value. Over the past three years, Karooooo has delivered a total return of 122.8%, which gives useful context to the shorter term moves...

Blackrock Silver Corp. participated in the Metals Investor Forum 2026 on January 24 at the Fairmont Pacific Rim in Vancouver, presenting its latest corporate and project updates to an audience of metals-focused investors. This conference appearance gives the company a stage to articulate how its exploration plans and capital priorities fit within current precious metals sector themes. We will now examine how Blackrock Silver’s investor forum presentation might shape its investment narrative...

Clover Health Investments (NasdaqGS:CLOV) is reporting strong customer growth for its Medicare Advantage plans and related technology solutions. The company is seeing an expanding free cash flow margin even as revenue has declined over the past two years. This mix of higher customer counts and improving cash generation, alongside revenue pressure, is a fresh development that investors are assessing. Clover Health focuses on Medicare Advantage insurance and technology driven care tools,...

Why Triple Flag’s latest revenue update matters for shareholders Triple Flag Precious Metals (TSX:TFPM) has caught investors’ attention after announcing preliminary record revenue of US$118.9 million for the fourth quarter and US$388.7 million for 2025, with gold equivalent ounces in the top half of guidance. See our latest analysis for Triple Flag Precious Metals. The latest revenue update lands after a strong run in the share price, with a 90 day share price return of 35.56% and a 1 year...

Key Insights The projected fair value for Temple & Webster Group is AU$13.87 based on 2 Stage Free Cash Flow to Equity...

BLS International Services Limited's ( NSE:BLS ) price-to-earnings (or "P/E") ratio of 18.8x might make it look like a...

FDA Breakthrough designation puts pemvidutide in focus Altimmune (ALT) has drawn fresh attention after the FDA granted Breakthrough Therapy Designation to its lead candidate pemvidutide for MASH, based on mid stage trial data showing significant disease resolution. See our latest analysis for Altimmune. The FDA Breakthrough Therapy news has arrived during a period of building momentum for Altimmune, with the 7 day share price return of 33.49% and year to date share price return of 61.25%...

Lanxess AG recently announced a price increase for adipic acid within its specialty chemicals portfolio, alongside plans to present at the 25th German Corporate Conference in Frankfurt on 21 January 2026, featuring IR managers Jens Ussler and Thomas Kaiser. This combination of a core product price adjustment and direct investor engagement highlights how Lanxess is actively managing its positioning in key chemical value chains. Next, we’ll examine how Lanxess’s adipic acid price increase...

If you are wondering whether Lumine Group is offering good value at its current share price, it helps to first line up what the market has been doing with the stock recently. Lumine Group shares last closed at CA$24.11, after a 1.5% decline over the past week, an 11.8% decline over 30 days and a 36.6% decline over the last year, which has likely changed how some investors think about its risk and potential. Recent coverage has focused on Lumine Group's position as a software player on the...

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other things...

Most Gulf markets have recently seen declines due to geopolitical and policy uncertainties, with investor sentiment cautious amid fluctuating oil prices and regional tensions. Despite these challenges, the search for growth opportunities continues, particularly in less conventional areas of the market. Penny stocks—often associated with smaller or newer companies—remain a relevant investment area that can offer significant returns when backed by strong financial health and fundamentals.

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

With its stock down 6.9% over the past month, it is easy to disregard RHI Magnesita India (NSE:RHIM). It seems that the...

Key Insights SITC International Holdings' estimated fair value is HK$49.34 based on 2 Stage Free Cash Flow to Equity...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

The Endomines Finland Oyj ( HEL:PAMPALO ) share price has done very well over the last month, posting an excellent gain...

As Middle Eastern markets navigate through geopolitical tensions and uncertainties surrounding U.S. policies, investors are closely watching the fluctuations in Gulf indices, with some regions experiencing declines while others show resilience. Amidst this backdrop, dividend stocks can offer a degree of stability and income potential, making them an attractive consideration for those seeking to balance risk with reliable returns in such volatile times.

Earlier this month, ASM International reported an upbeat early Q4 2025 update, indicating that Q1 2026 revenue at constant currencies should rise healthily, supported by demand from leading-edge foundry and logic customers. Berenberg responded by upgrading its medium-term forecasts for ASM International’s sales, EBIT, and EPS, highlighting the importance of steadier capital spending signals from major customers such as TSMC and Intel for the company’s order outlook. We will now examine how...

Docebo (TSX:DCBO) is back on investor radars after launching a credit-based pricing model for its AI-powered modules and securing new enterprise wins, along with deeper usage within large existing customers. See our latest analysis for Docebo. That product progress and recent analyst attention come against a weak share price backdrop, with a 30 day share price return of a 14.15% decline and a 1 year total shareholder return of a 58.02% decline. This suggests momentum has been fading even as...

If you are wondering whether Manulife Financial's current share price lines up with its underlying value, you are not alone. The stock last closed at C$50.89, with a 2.4% decline over the past 7 days, a 1.5% gain over 30 days, a 2.2% gain year to date, a 21.4% return over 1 year and a 124.2% return over 3 years, while the 5 year return is very large. Recent attention on Manulife Financial has been shaped by ongoing discussion around large insurers, interest rate expectations and how...